JP4336960B2 - 複室容器 - Google Patents
複室容器 Download PDFInfo
- Publication number
- JP4336960B2 JP4336960B2 JP2003359447A JP2003359447A JP4336960B2 JP 4336960 B2 JP4336960 B2 JP 4336960B2 JP 2003359447 A JP2003359447 A JP 2003359447A JP 2003359447 A JP2003359447 A JP 2003359447A JP 4336960 B2 JP4336960 B2 JP 4336960B2
- Authority
- JP
- Japan
- Prior art keywords
- sealing portion
- container
- storage
- chamber
- discharge
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000007789 sealing Methods 0.000 claims description 80
- 238000005192 partition Methods 0.000 claims description 40
- 239000003814 drug Substances 0.000 claims description 38
- 239000000463 material Substances 0.000 claims description 27
- 238000007599 discharging Methods 0.000 claims description 3
- 239000011344 liquid material Substances 0.000 claims description 3
- 229940079593 drug Drugs 0.000 description 15
- 239000012530 fluid Substances 0.000 description 14
- 239000007788 liquid Substances 0.000 description 11
- -1 polyethylene Polymers 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 239000000843 powder Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 229920001971 elastomer Polymers 0.000 description 3
- 230000009969 flowable effect Effects 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000000118 hair dye Substances 0.000 description 2
- 239000003978 infusion fluid Substances 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 239000005060 rubber Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- MWWSFMDVAYGXBV-FGBSZODSSA-N (7s,9s)-7-[(2r,4s,5r,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione;hydron;chloride Chemical compound Cl.O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 MWWSFMDVAYGXBV-FGBSZODSSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229960004562 carboplatin Drugs 0.000 description 1
- 190000008236 carboplatin Chemical compound 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 229960003668 docetaxel Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 229960003265 epirubicin hydrochloride Drugs 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 229920002457 flexible plastic Polymers 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229910052809 inorganic oxide Inorganic materials 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 239000002960 lipid emulsion Substances 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- ZAHQPTJLOCWVPG-UHFFFAOYSA-N mitoxantrone dihydrochloride Chemical compound Cl.Cl.O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO ZAHQPTJLOCWVPG-UHFFFAOYSA-N 0.000 description 1
- 229960004169 mitoxantrone hydrochloride Drugs 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920005672 polyolefin resin Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229960004641 rituximab Drugs 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- WFWLQNSHRPWKFK-ZCFIWIBFSA-N tegafur Chemical compound O=C1NC(=O)C(F)=CN1[C@@H]1OCCC1 WFWLQNSHRPWKFK-ZCFIWIBFSA-N 0.000 description 1
- 229960001674 tegafur Drugs 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 238000007740 vapor deposition Methods 0.000 description 1
- 229960002166 vinorelbine tartrate Drugs 0.000 description 1
- GBABOYUKABKIAF-IWWDSPBFSA-N vinorelbinetartrate Chemical compound C1N(CC=2C3=CC=CC=C3NC=22)CC(CC)=C[C@H]1C[C@]2(C(=O)OC)C1=CC(C23[C@H]([C@@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC GBABOYUKABKIAF-IWWDSPBFSA-N 0.000 description 1
Images
Landscapes
- Package Specialized In Special Use (AREA)
- Bag Frames (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Description
5 容器本体
9,11 収納室
13 仕切り用封止部
15 排出用封止部
Claims (2)
- 各種材料がそれぞれ収納された複数の収納室及びこれら収納室を仕切る直線状の仕切り用封止部を有する容器本体と、当該容器本体に取り付けられ前記収納室から薬剤を排出可能な排出部とを備え、前記仕切り用封止部が使用に際して開封されることで前記複数の収納室が連通される複室容器であって、
前記容器本体は、第1面及び第2面を有する扁平状に形成され、
前記収納室のうち、前記排出部を備える前記収納室は、排出規制用封止部によって、前記排出部を備えた第1の収納部と前記仕切り用封止部を備えた第2の収容部とに区画され、
前記第1の収納部には前記各種材料は収納されておらず、
前記第2の収納部には液体状の材料が、前記第2の収納部における前記第1面及び前記第2面のいずれか一方の面の1〜25%の面積に相当する部分を押圧したときに、前記第1面及び前記第2面の内壁面同士が接触するよう収納されており、
前記容器本体は当該仕切り用封止部に沿って二つ折りにされている複室容器。 - 前記第2の収納部には液体状の材料が、前記第2の収納部における前記第1面及び前記第2面のいずれか一方の面の25%の面積に相当する部分を押圧したときに、前記第1面及び前記第2面の内壁面同士が接触するよう収納されている、請求項1に記載の複室容器。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003359447A JP4336960B2 (ja) | 2003-10-20 | 2003-10-20 | 複室容器 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003359447A JP4336960B2 (ja) | 2003-10-20 | 2003-10-20 | 複室容器 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005118445A JP2005118445A (ja) | 2005-05-12 |
JP4336960B2 true JP4336960B2 (ja) | 2009-09-30 |
Family
ID=34615672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003359447A Expired - Fee Related JP4336960B2 (ja) | 2003-10-20 | 2003-10-20 | 複室容器 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4336960B2 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5352453B2 (ja) | 2006-06-15 | 2013-11-27 | メットプロ アーベー | 溶液を提供するための容器、システムならびに方法 |
JP4984228B2 (ja) * | 2006-12-20 | 2012-07-25 | 大日本印刷株式会社 | 注出具付き包装袋およびその製造方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3079403B2 (ja) * | 1992-05-03 | 2000-08-21 | 株式会社大塚製薬工場 | 複室容器 |
JPH09239000A (ja) * | 1996-03-07 | 1997-09-16 | Otsuka Pharmaceut Factory Inc | デキストラン注射液充填容器およびその製造方法 |
JP3070596U (ja) * | 2000-01-28 | 2000-08-04 | 株式会社大塚製薬工場 | 複室容器 |
JP2001299912A (ja) * | 2000-02-17 | 2001-10-30 | Koriryo Yugenkoshi | 注射用キット及び注射用器具 |
JP2002136570A (ja) * | 2000-08-24 | 2002-05-14 | Otsuka Pharmaceut Factory Inc | 医療用複室容器 |
JP2003116963A (ja) * | 2001-10-11 | 2003-04-22 | Nipro Corp | 医療用容器 |
JP2003284758A (ja) * | 2002-03-27 | 2003-10-07 | Jms Co Ltd | 複室式薬液容器 |
-
2003
- 2003-10-20 JP JP2003359447A patent/JP4336960B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2005118445A (ja) | 2005-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2007248194B2 (en) | Multiple chamber container with mistake proof administration system | |
TWI401076B (zh) | 醫療用多室容器之弱密封部的補強方法 | |
KR100871204B1 (ko) | 의료용 약액 용기 및 약제-함입 의료용 약액 용기 | |
JP2010522677A (ja) | マルチコンパートメントパッケージ | |
JP4854940B2 (ja) | 医療用複室容器 | |
JP4920246B2 (ja) | 医療用薬液容器および薬剤入り医療用薬液容器 | |
EP2568950B1 (en) | Handling | |
JP2005245677A (ja) | 未混合防止機構つき医療用複室容器 | |
JP4336960B2 (ja) | 複室容器 | |
JP4708234B2 (ja) | 医療用複室容器 | |
JP2005000228A (ja) | 医療用複室容器 | |
JP3139180U (ja) | 包装済みプレフィルドシリンジ | |
JP4787646B2 (ja) | 医療用容器 | |
JP3121155U (ja) | 医療用複室容器 | |
JP5053620B2 (ja) | 医療用複室容器の弱シール部の補強方法 | |
JP4186448B2 (ja) | 輸液バッグ | |
JP2009195470A (ja) | 医療用複室容器 | |
JP2005143594A (ja) | 医療用複室容器 | |
JP4476598B2 (ja) | 複室輸液容器及び薬剤入り複室輸液容器 | |
JP4708248B2 (ja) | 医療用容器 | |
JP2004313487A (ja) | 医療用複室容器及びその製造方法 | |
JP5363788B2 (ja) | 複室容器 | |
JP2006255378A (ja) | 少容量容器 | |
JP2006141857A (ja) | 包装材に収納された医療用複室容器 | |
JP5781336B2 (ja) | 医療用複室容器 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060613 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090225 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20090226 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090427 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090527 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20090616 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4336960 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120710 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130710 Year of fee payment: 4 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130710 Year of fee payment: 4 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |